Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.
The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type 2 diabetes manage their ...
A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Achieved first-ever RNA editing in humans in RestorAATion-2 trial of WVE-006 (GalNAc-AIMer) in alpha-1 antitrypsin deficiency and announced ... for synergistic use with GLP-1s, and for maintenance to ...
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual ...
Hosted on MSN15h
Is Ozempic the modern wonder drug? All the conditions the weight loss jab can tackle — from addiction to Alzheimer’sGLP-1 drugs may be able to treat alcohol and opioid addiction by ... Polycystic ovary syndrome PCOS is a hormonal imbalance ...
Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback